Description
In specialized mitochondrial and cellular protection models, combining the SS-31 ARA-290 blend delivers a highly advanced dual-action framework. Rather than acting on basic tissue networks, this synergistic profile targets mitochondrial bioenergetics alongside specific peripheral nerve repair tracks.
Core Research Focus
Pathway Synergy: Links inner mitochondrial stability directly with tissue-protective signaling pathways to maximize cellular defense.
Structural Cell Shielding: Enables modern laboratories to gain definitive insights into cellular stamina, peripheral nerve adaptation, and longevity behaviors using pure SS-31 ARA-290 blend.
Comparative Research Options: To evaluate this dual-action blend alongside standalone mitochondrial cardiolipin targeting, explore our SS-31 Research Peptide. You can also review our laboratory quality standards on our About Us Page.
Technical Specifications
| Specification | Details |
| Primary Target | Inner Mitochondrial Membrane & Erythropoietin Receptor (EPOR) Pathways |
| Documentation | COA verified peptides status included |
| Category | Mitochondrial & Cellular Peptides & Peptide Bioregulators |
| Format | Sterile Lyophilized Powder Blend |
Handling & Storage Guidelines
Storage Condition: Lock the dry vial away in deep freeze storage at -20°C for long-term stability, protected from direct light exposure.
Reconstitution & Handling: Reconstitute gently by running liquid media down the inside vial wall to preserve structural integrity. For indexed literature and PubMed research on mitochondrial protective peptides, consult PubMed SS-31 ARA-290 Studies.
Usage Safety: Protect from sharp temperature shifts post-reconstitution and avoid multiple freeze-thaw cycles to keep the setup stable.
Research Disclaimer: This compound is synthesized strictly for laboratory research and development purposes. It is not intended for human therapeutic, diagnostic, or clinical use.
Reviews
There are no reviews yet.